Loading clinical trials...
Loading clinical trials...
The purpose of this prospective, multi-center, propensity-matched coverage with evidence development (CED) study is to assess the impact of cardiac contractility modulation (CCM) on mortality and hear...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Impulse Dynamics
NCT07243119 · Heart Failure and Reduced Ejection Fraction, Heart Failure
NCT07064525 · Hypertension (HTN), NYHA Class III Heart Failure, and more
NCT07547306 · Heart Failure and Reduced Ejection Fraction
NCT07275437 · Heart Failure, Heart Failure and Reduced Ejection Fraction, and more
NCT02939053 · NYHA Class III Heart Failure
Impulse Dynamics
Marlton, New Jersey
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions